Rubicon Organics Inc. produces and sells organic cannabis for both recreational and medical markets in Canada. The company shows strengths in its gross margin of 41.3% and a solid current ratio of 2.21, indicating good liquidity. However, concerns arise from its low net margin of 2.2% and minimal returns on equity and assets, suggesting profitability challenges. While the gross margin is strong, the overall valuation at $0.44 may reflect market skepticism about future growth potential.
Read our deep dive
Rubicon Organics: A Premium Cannabis Brand Waiting on Its Second Greenhouse
Rubicon Organics (TSXV: ROMJ) posted a record $18.5M quarter, yet the whole company trades for about half a year's sales. Here's what the bet on its new Cascadia greenhouse means for investors.
Loading financial metrics...
Debt of $15.6M is 5.3x the company's cash position of $3.0M.
Company went from $235K profit to $-1.7M loss compared to last year.
Strong revenue growth of 16.7% YoY indicates solid business momentum.
Low debt-to-revenue ratio of 24.3% indicates conservative financial management.
Strong liquidity position with current ratio of 2.2x.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)